176 related articles for article (PubMed ID: 29735551)
1. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Vaisitti T; Braggio E; Allan JN; Arruga F; Serra S; Zamò A; Tam W; Chadburn A; Furman RR; Deaglio S
Cancer Res; 2018 Jul; 78(13):3413-3420. PubMed ID: 29735551
[TBL] [Abstract][Full Text] [Related]
2. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
3. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
4. Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models.
Iannello A; Vitale N; Coma S; Arruga F; Chadburn A; Di Napoli A; Laudanna C; Allan JN; Furman RR; Pachter JA; Deaglio S; Vaisitti T
Blood; 2021 Jun; 137(24):3378-3389. PubMed ID: 33786583
[TBL] [Abstract][Full Text] [Related]
5. The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and Beyond.
Ding W
Hematol Oncol Clin North Am; 2021 Aug; 35(4):739-759. PubMed ID: 34174984
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
7. Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.
Vaisitti T; Gaudino F; Ouk S; Moscvin M; Vitale N; Serra S; Arruga F; Zakrzewski JL; Liou HC; Allan JN; Furman RR; Deaglio S
Haematologica; 2017 Nov; 102(11):1878-1889. PubMed ID: 28860341
[TBL] [Abstract][Full Text] [Related]
8. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.
Seda V; Mraz M
Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849
[TBL] [Abstract][Full Text] [Related]
9. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
Fabbri G; Khiabanian H; Holmes AB; Wang J; Messina M; Mullighan CG; Pasqualucci L; Rabadan R; Dalla-Favera R
J Exp Med; 2013 Oct; 210(11):2273-88. PubMed ID: 24127483
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
Playa-Albinyana H; Arenas F; Royo R; Giró A; López-Oreja I; Aymerich M; López-Guerra M; Frigola G; Beà S; Delgado J; Garcia-Roves PM; Campo E; Nadeu F; Colomer D
Leukemia; 2024 Mar; 38(3):557-569. PubMed ID: 38017105
[TBL] [Abstract][Full Text] [Related]
12. The involvement of microRNA in the pathogenesis of Richter syndrome.
Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
[TBL] [Abstract][Full Text] [Related]
13. An update for Richter syndrome - new directions and developments.
Eyre TA; Schuh A
Br J Haematol; 2017 Aug; 178(4):508-520. PubMed ID: 28439883
[TBL] [Abstract][Full Text] [Related]
14. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Rasi S; Spina V; Fangazio M; Monti S; Greco M; Ciardullo C; Famà R; Cresta S; Bruscaggin A; Laurenti L; Martini M; Musto P; Forconi F; Marasca R; Larocca LM; Foà R; Gaidano G
Br J Haematol; 2012 Aug; 158(3):426-9. PubMed ID: 22571487
[No Abstract] [Full Text] [Related]
15. Richter transformation in the era of novel agents.
Ding W
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):256-263. PubMed ID: 30504319
[TBL] [Abstract][Full Text] [Related]
16. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
Chigrinova E; Rinaldi A; Kwee I; Rossi D; Rancoita PM; Strefford JC; Oscier D; Stamatopoulos K; Papadaki T; Berger F; Young KH; Murray F; Rosenquist R; Greiner TC; Chan WC; Orlandi EM; Lucioni M; Marasca R; Inghirami G; Ladetto M; Forconi F; Cogliatti S; Votavova H; Swerdlow SH; Stilgenbauer S; Piris MA; Matolcsy A; Spagnolo D; Nikitin E; Zamò A; Gattei V; Bhagat G; Ott G; Zucca E; Gaidano G; Bertoni F
Blood; 2013 Oct; 122(15):2673-82. PubMed ID: 24004666
[TBL] [Abstract][Full Text] [Related]
17. [Richter syndrome: report of a case].
Chen DB; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
[No Abstract] [Full Text] [Related]
18. Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia.
Fløisand Y; Delabie J; Fosså A; Helseth E; Jacobsen EA; Rolke J; Tjønnfjord GE
Leuk Lymphoma; 2011 Oct; 52(10):2007-9. PubMed ID: 21663503
[No Abstract] [Full Text] [Related]
19. Richter transformation in Chronic Lymphocytic Leukemia.
Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
[TBL] [Abstract][Full Text] [Related]
20. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]